Trials / Conditions / Glomerulonephritis, Membranous

Glomerulonephritis, Membranous

16 registered clinical trials studyying Glomerulonephritis, Membranous — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Clinical Study of Rituximab for the Treatment for Idiopathic Membranous Nephropathy with Nephrotic Syndrome NCT05914155	Shoichi Maruyama MD PhD	Phase 3
Unknown	Application of Hyperspectral Imaging in the Diagnosis of Glomerular Diseases NCT05797051	Qianfoshan Hospital	—
Unknown	The Influencing Factors and Mechanism of High Incidence of Thrombotic Events in Patients With MN and DKD NCT05656963	Yipeng Liu	—
Completed	Trial to Assess Safety and Efficacy of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN) NCT04145440	HI-Bio, A Biogen Company	Phase 1 / Phase 2
Completed	Rituximab in Refractory Primary Membranous Nephropathy NCT03880643	Istanbul University	—
Withdrawn	Efficacy and Safety Study of Intravenous Belimumab Versus Placebo in Subjects With Idiopathic Membranous Nephr NCT01762852	GlaxoSmithKline	Phase 2
Completed	A Study of Belimumab in Idiopathic Membranous Glomerulonephropathy NCT01610492	GlaxoSmithKline	Phase 2
Unknown	Rituximab Versus Steroids and Cyclophosphamide in the Treatment of Idiopathic Membranous Nephropathy NCT03018535	Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia	Phase 3
Completed	Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous Nephropathy NCT01282073	Kyungpook National University Hospital	Phase 3
Terminated	Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney NCT01129557	Columbia University	Phase 4
Completed	Mycophenolate Mofetil and Tacrolimus Versus Tacrolimus for the Treatment of Idiopathic Membranous Glomerulonep NCT00843856	Imperial College Healthcare NHS Trust	Phase 4
Completed	A Study to Compare Mycophenolate Mofetil and Tacrolimus in the Treatment of Membranous Lupus Nephritis NCT00404794	Hospital Authority, Hong Kong	Phase 3
Completed	Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization NCT00199628	University Hospital, Limoges	—
Completed	Mycophenolate Mofetil in Membranous Nephropathy and Focal Segmental NCT00404833	Hospital Authority, Hong Kong	Phase 3
Completed	Mycophenolate Mofetil in Membranous Nephropathy NCT00135967	Radboud University Medical Center	Phase 2 / Phase 3
Completed	Treatment of Patients With Idiopathic Membranous Nephropathy NCT00135954	Radboud University Medical Center	Phase 3